Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448786
Status:
COMPLETED
Last Update Posted:
2011-01-21
First Post:
2007-03-15
Brief Title:
Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
An Open-Label Randomized Phase 1b Study Evaluating the Effect of Different Doses of AMG 706 on the Gallbladder in Subjects With Advanced Solid Tumors
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study involves the use of three different dosing regimens of AMG 706 in patients with advanced solid tumors to see how the drug affects the gallbladder size and function The study will be conducted in 11 sites in the US and Australia A total of 48 patients will be enrolled in the study with the possibility of enrolling 8 more in each treatment arm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None